RPS BioPharma is a Other Investment Fund in Cayman Islands, that has raised $149.58 mm from 21 investors, with a minimum investment of $100.00 k, for an equity fund started in Mar 2017. Data from SEC filing on 9 Apr 2017.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
Address
RPS BioPharma
190 ELGIN AVENUE
GEORGE TOWN
E9 KY1-9001
190 ELGIN AVENUE
GEORGE TOWN
E9 KY1-9001
Phone
212-883-0200
Ownership
Fund structure | AUM | Fund type |
---|---|---|
RP Management, LLC | $17.71 bn | |
Royalty Pharma Select | $72.14 mm | Private Equity Fund |
Royalty Pharma Cayman Holdings 2008, LP | ||
Royalty Pharma Cayman Holdings, LP | ||
Royalty Pharma Us Partners LP | ||
Royalty Pharma Us Partners 2008, LP | ||
Royalty Pharma Cayman Partners, LP | ||
Royalty Pharma Cayman Partners 2008, LP | ||
RPS Biopharma Investments, LP | ||
RPS Biopharma Holdings, LP | ||
Rpi Intermediate Finance Partnership, LP | $1.94 bn | Hedge Fund |
Rpi International Partners II, LP | ||
Rpi International Partners, LP | ||
Rpi Us Partners, LP | ||
Rpi Us Partners II, LP | ||
Rpi International Holdings, LP | ||
Rpi International Partners 2019, LP | $23.12 mm | Private Equity Fund |
Rpi International Holdings 2019, LP | ||
Rpi Us Partners 2019, LP | $1.67 bn | Private Equity Fund |
Latest filings (excl ownership)
Latest ownership filings
No filings